Open-label Feasibility Study for the Treatment of Psychotic Adolescents With Ziprasidone in the Inpatient and Day Hospital Settings.
Phase of Trial: Phase III
Latest Information Update: 19 Jan 2017
At a glance
- Drugs Ziprasidone (Primary)
- Indications Psychotic disorders
- Focus Adverse reactions
- 21 Jul 2011 Actual end date (May 2009) added as reported by ClinicalTrials.gov.
- 18 May 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 29 Jan 2007 New trial record.